Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer

BACKGROUND: The prognostic value of lymphovascular invasion (LVI) in breast cancer (BC) has been demonstrated in several independent studies. However, identification of driver molecules for LVI remains a challenging task. Large-scale transcriptomic profiling of histologically validated LVI can poten...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Aleskandarany, Mohammed A, Sonbul, Sultan, Surridge, Rachel, Mukherjee, Abhik, Caldas, Carlos, Diez-Rodriguez, Maria, Ashankyty, Ibraheem, Albrahim, Khalil I, Elmouna, Ahmed M, Aneja, Ritu, Martin, Stewart G, Ellis, Ian O, Green, Andrew R, Rakha, Emad A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674094/
https://ncbi.nlm.nih.gov/pubmed/28829761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados